Metropolitan Life Insurance Company (MetLife)’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,812
| Closed | -$122K | – | 1719 |
|
|
2024
Q1 | $122K | Sell |
2,812
-156
| -5% | -$6.76K | 0.01% | 951 |
|
|
2023
Q4 | $136K | Hold |
2,968
| – | – | 0.01% | 922 |
|
|
2023
Q3 | $68K | Buy |
2,968
+157
| +6% | +$3.6K | ﹤0.01% | 1224 |
|
|
2023
Q2 | $46.4K | Buy |
+2,811
| New | +$46.4K | ﹤0.01% | 1465 |
|
|
2022
Q2 | – | Sell |
-3,036
| Closed | -$35K | – | 2424 |
|
|
2022
Q1 | $35K | Sell |
3,036
-4,498
| -60% | -$51.8K | ﹤0.01% | 1797 |
|
|
2021
Q4 | $75.2K | Sell |
7,534
-1,259
| -14% | -$12.6K | ﹤0.01% | 2612 |
|
|
2021
Q3 | $115K | Sell |
8,793
-3,657
| -29% | -$47.8K | ﹤0.01% | 2446 |
|
|
2021
Q2 | $244K | Buy |
12,450
+2,835
| +29% | +$55.5K | ﹤0.01% | 2002 |
|
|
2021
Q1 | $205K | Sell |
9,615
-487
| -5% | -$10.4K | ﹤0.01% | 2006 |
|
|
2020
Q4 | $300K | Hold |
10,102
| – | – | ﹤0.01% | 1678 |
|
|
2020
Q3 | $219K | Hold |
10,102
| – | – | ﹤0.01% | 1710 |
|
|
2020
Q2 | $225K | Hold |
10,102
| – | – | ﹤0.01% | 1718 |
|
|
2020
Q1 | $154K | Buy |
10,102
+665
| +7% | +$10.1K | ﹤0.01% | 1755 |
|
|
2019
Q4 | $217K | Buy |
9,437
+1,293
| +16% | +$29.7K | ﹤0.01% | 1864 |
|
|
2019
Q3 | $176K | Buy |
8,144
+2,953
| +57% | +$63.8K | ﹤0.01% | 1962 |
|
|
2019
Q2 | $114K | Buy |
5,191
+689
| +15% | +$15.2K | ﹤0.01% | 2229 |
|
|
2019
Q1 | $123K | Sell |
4,502
-518
| -10% | -$14.2K | ﹤0.01% | 2197 |
|
|
2018
Q4 | $135K | Buy |
5,020
+647
| +15% | +$17.4K | ﹤0.01% | 2081 |
|
|
2018
Q3 | $128K | Buy |
+4,373
| New | +$128K | ﹤0.01% | 2304 |
|
|
2018
Q1 | – | Sell |
-6,757
| Closed | -$196K | – | 2492 |
|
|
2017
Q4 | $196K | Buy |
+6,757
| New | +$196K | ﹤0.01% | 1922 |
|